维普期刊资源整合服务平台（V6.5）

11865篇 您的检索式：期刊名="J Nucl Med"

选中清除导出查看参考文献查看引证文献引用追踪共594页首页上一页第1页下一页末页 /594 跳转

	题名	作者	年代	出处	被引量
1	Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia显示文摘	Yutani K Kusuoka H Fukuchi K	1999	J Nucl Med1999，40，：	2
2	Radiolabeled nucleoside analogs in cancer diagnosis and therapy显示文摘	Kassis AI Adelstein SJ Mariani G	1996	Q J Nucl Med1996，40，：	2
3	Radioiododeoxyu-eidine in cancer therapy: an in vitro approach to developing in vivo strategies显示文摘	Schneiderman MH Schneiderman GS	1996	J Nucl Med1996，37，：	2
4	Establishment and characterization of a breast cancer cell line expressing Na+/I-symporter for radioiodide concentrator gene therapy显示文摘	Nakamato Y Saga T Misaki T	2000	J Nucl Med2000，41，：	2
5	Report of the radionuclides in nephrourology committee on renal clearance 显示文摘	Blaufox MD Aurell M Bubeck B	1996	J Nucl Med1996，37，：	2
6	99Tcmlabeled HL91 to identify tumor hypoxia:correlation with fluorine-18 FDG显示文摘	Cook GJ Houston S Barrington SF	1998	J Nucl Med1998，39，1：	2
7	Differential diagnosis of Parkinson's disease and vascular parkinsonism by 99mTc-TRODAT-1显示文摘	Tzen KY Lu CS Yen TC	2001	J Nucl Med2001，42，3：	2
8	The basics of renal imaging and function studies显示文摘	Durand E Prigent A	2002	Q J Nucl Med2002，46，：	2
9	Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma显示文摘	Schoder H Meta J Yap C	2001	J Nucl Med2001，42，8：	2
10	Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography显示文摘	Klose T Leidl R Buchmann I	2000	Eur J Nucl Med2000，27，10：	2
11	PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease 显示文摘	Kostakoglu L Coleman M Leonard P	2002	J Nucl Med2002，43，8：	2
12	Does SPECT Actually have Lower Sensitivity for Detecting Vertebral Metastasis than MRI 显示文摘	Kosuda S Kaji T Yokoyama H	1996	J Nucl Med1996，37，6：	1
13	Comparative analysis of striatal F- DOPA uptake in Parkinson's disease:ratio method versus graphical approach 显示文摘	Dahwan V Ma Y Pillai V	2002	J Nucl Med2002，43，：	1
14	Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease显示文摘	OKAZAWA H YAMAUCHI H SUGIMOTO K	2003	J Nucl Med2003，44，9：	1
15	Biodistribution and radiation dosimetry of the amyloid imaging agent ^11C-PIB in humans显示文摘	Scheinin NM Tolvanen TK Wilson IA	2007	J Nucl Med2007，48，1：	1
16	^186Re-HDD/Lipiodol for Treatment of Hepatocetluar Carcinoma: A Feasibility Study in Patents With Advanced Cirrhosis 显示文摘	Lambert B Bacher K De Kukeleire K	2005	J Nucl Med2005，46，8：	1
17	Early prediction of endocrine therapy effect in advanced breast cancer patients using ^99mTc-depreotide scintigraphy 显示文摘	VAN DEN BOSSCHE B VAN BELLE S DE WINTER F	2006	J Nucl Med2006，47，11：	1
18	Postitron emission tomography with selected mediastinoseopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer显示文摘	Yap KK Yap KS Byrne A J	2005	Eur J Nucl Med Mol Imaging2005，32，9：	1
19	99mTc-DPD Scintigraphy in Transthyretin-related Familial Amyloidotic Polyneuropathy显示文摘	Puille M Altland K Linke RP	2002	Eur J Nucl Med2002，29，3：	1
20	Usefulness of ^11C-mathionine PET in the evaluation of brain lesions that are hypo-or isometabolic on ^18F-FDG PET显示文摘	Chung JK Kim YK Kim SK	2002	Eur J Nucl Med Mol Imaging2002，29，2：	1

返回顶部每页显示：

共594页首页上一页第1页下一页末页 /594 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示